Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117M
-
Number of holders
-
148
-
Total 13F shares, excl. options
-
80.7M
-
Shares change
-
+15.1M
-
Total reported value, excl. options
-
$716M
-
Value change
-
+$142M
-
Put/Call ratio
-
0.42
-
Number of buys
-
100
-
Number of sells
-
-36
-
Price
-
$8.87
Significant Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q2 2020
175 filings reported holding DVAX - DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value as of Q2 2020.
DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) has 148 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 80.7M shares
of 117M outstanding shares and own 68.82% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (11.2M shares), Bain Capital Life Sciences Investors, LLC (10.9M shares), BlackRock Inc. (6.97M shares), Redmile Group, LLC (5.06M shares), STATE STREET CORP (5.06M shares), VANGUARD GROUP INC (4.99M shares), Chicago Capital, LLC (4.9M shares), CITADEL ADVISORS LLC (2.93M shares), Avidity Partners Management LP (2.67M shares), and BLAIR WILLIAM & CO/IL (2.03M shares).
This table shows the top 148 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.